Medical cannabis has shown effectiveness in alleviating various symptoms of depression, such as anxiety, insomnia, and reduced appetite. It achieves this by targeting the endocannabinoid system, which plays a pivotal role in how the body maintains chemical balance in the brain, which is crucial for managing depression. However, results often depend on selecting the appropriate varieties.
Depression is currently one of the most frequently diagnosed mental disorders that takes away the will to live and make daily functioning difficult. Treatment primarily involves taking antidepressants and psychotherapy, but there’s also a lot of discussion about the positive impact of cannabis on this disease. Check whether the properties of cannabis can reduce the symptoms of depression and improve the quality of patients’ lives.
Depression is a disease related to the disturbance in the balance of neurotransmitter secretion and flow, which are responsible for emotions and mood. Such a state is most often brought about by experienced events, such as:
The likelihood of developing depression also increases in people exposed to chronic stress, young people entering adulthood, older people, and women in the perinatal period.
Chemical imbalances in the brain lead to a prolonged deterioration of mood and the feeling of various kinds of ailments both mentally and physically.
Among the main symptoms of depression are:
A long-term presence of several of the above symptoms may indicate depression, but for an accurate diagnosis, consultation with a doctor is recommended.
Cannabis affects the body through the endocannabinoid system, which is one of the basic systems of the human body. It participates in many functions and processes, such as appetite, sleep, immunity, metabolism, and mood, and is also responsible for maintaining internal balance.
The endocannabinoid system consists of:
Cannabinoid receptors are distributed throughout the body. They are present in every system and organ of the human body, including the nervous system and the brain. Cannabinoids THC and CBD contained in cannabis connect with the receptors, affecting the body and showing health properties in the form of, among others, restoring the chemical balance in the brain – the main cause of depression.
This action of cannabis on the body improves mood and alleviates other ailments associated with depression, such as reduced appetite, sleep problems, or prolonged lack of energy.
In the treatment of depression, medical cannabis is used more and more often due to its comprehensive therapeutic action. However, choosing the right variety of cannabis is essential for symptom significance. In the case of depression, cannabis with a high content of cannabidiol CBD is the best.
Many studies conducted on patients with depression have shown that over half of the patients who took medical cannabis felt an improvement in mood. Medical cannabis also positively affected other ailments related to depression, including anxiety disorders, sleep problems, reduced appetite, and stress.
Cannabis contains many compounds that more or less affect the body. Besides cannabinoids, which are present in cannabis in the highest concentrations, terpenes also deserve attention.
Terpenes are volatile compounds responsible for the taste and smell of plants. They also show numerous health properties and enhance the action of cannabinoids, commonly referred to as the synergy effect.
So far, over 20,000 terpenes have been discovered, and each of them differs in action. In the case of depression, linalool is especially crucial, possessing antidepressant properties.
Linalool’s action is similar to the antidepressant effect of CBD. This terpene captures serotonin and increases its level in the brain, improving mood as a result. It also activates noradrenergic receptors, properties used in the action mechanism of antidepressant drugs.
Substances found in medical cannabis, such as cannabinoids and terpenes, are successfully used in treating depression. However, achieving the best therapeutic effects is essential to selecting appropriate cannabis varieties and a short duration of their administration.
Medical cannabis improves patients’ well-being and also positively affects other ailments related to depression. Its use effectively reduces anxiety states, insomnia, and fatigue, and also improves appetite, as confirmed in numerous clinical studies.
—
(Featured image by Nik Shuliahin via Unsplash)
DISCLAIMER: This article was written by a third-party contributor and does not reflect the opinion of Hemp.im, its management, staff, or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the company may believe that its expectations are based on reasonable assumptions, the actual results that the company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in Fakty Konopne, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
Based on 2023 sales, the United States saw a record high in tax revenues from…
A study by the French Observatory of Drugs and Addictions reveals that one in four…
High Times, once a leading cannabis culture magazine, faces severe financial troubles, prompting a potential…
The DEA plans to reclassify cannabis from Schedule I to Schedule III of the Controlled…
Germany is advancing its cannabis policy by launching Pillar 2, which involves five-year pilot projects…
A new study has revealed that rolling papers can contain heavy metals and chemical residues…